The intracellular production of nitric oxide is studied as a relevant phenomenon in exposure to ioniz- 
INTRODUCTION
Production of free radicals and oxidizing species by ionizing radiation in aqueous media is a well-known characteristic of exposures. The production of reactive oxygen (ROS) and nitrogen (RNS) species comprises a set of phenomena whose scope may include effects on DNA molecules [1] , blockade of cell division [2] , activation of necrosis pathways [3] and nitrosylation of proteins [4] . Studies aimed at understanding the bystander effects of radiation suggested that the damage from ionizing radiation transcends the paradigm linking cell death strongly to breaking of DNA strands, [5] , and more recent papers evaluating the effects of anti -and pro -oxidant molecules discuss the central role of RNS in certain pathologies, including cancer [6, 7] .
From this point of view, the production of RNS would be as or more harmful than the ROS, once the body has a greater variety of defenses against oxidative radicals (such as peroxidases), than against reactive nitrogen species [3] . Nitric oxide (NO) produced by nitric oxide synthases as well as exogenous NO donor drugs increase the radiosensitivity of hypoxic tumor cells via reduction of hypoxia through increased tumor perfusion [5] , and it was suggested that NO is a more potent radiosensitizer than oxygen [8] . Moreover, it was observed toxicity of NO due both to itself than with the NO oxidizing reactive derivatives. The modest toxicity of NO is increased by fast connections between NO and O 2 -, forming ONOO -(peroxynitrite), which is a more potent oxidant with toxic and nitrosative properties proteins, which may produce greater pathological consequences [9] . Therefore, it is difficult to identify the specific role of NO in carcinogenesis because it is dependent on its concentration, interaction with other free radicals, metal ions and proteins, as the cell type and genetic background.
NO can both cause damage to DNA and protect from cytotoxicity, can inhibit and stimulate cell proliferation and can be both pro and anti-apoptotic [10, 11] . Aminoguanidine, a specific inhibitor of nitric oxide synthase 2 (NOS2) [12] was used in cell cultures of human breast tumor (MCF7) in order to observe cytotoxicity, alterations on clonogenic potential and genotoxicity in experimental situations in which the balance of NO production has been changed.
MATERIALS AND METHODS

Cell Culture and solutions
Human breast adenocarcinoma cells (MCF-7, ATCC# HTB-22) were maintained in 25cm 2 flasks with RPMI 1640 (Gibco®, Grand Island, NY) medium supplemented with 10% fetal bovine serum (GIBCO-United states) and antibiotics mixture (1% penicillin / streptomycin, (GIBCO, Grand Insland, NY) until 60-70% confluency. All incubations and propagation of cells were carried out in a humid and controlled atmosphere (37ºC; 5% CO 2 ). After thawing, cells were kept growing for no more than 10 sub cultivation steps. When required, cells were washed using PBS with EDTA (5mM) and trypsinized (trypsin 0,5%). Using trypan blue exclusion test, only viable cells were used in experiments.
Aminoguanidine IC 50%
Tripsinized cells were suspended in culture medium, and aliquots were assayed for viable cell concentration using trypan blue exclusion test in a hematocytometer under microscope observation. Cells were seeded on 96-well plates (5000 viable cells / well in 200 µL) and were allowed to adhere for 24 hours. Medium from wells was replaced by fresh media (blank and cell control wells) or with increasing concentrations of aminoguanidine hydrochloride (Cat.#396494, Sigma-Aldrich, St.Louis, MO,) dissolved in medium. One set of experiments assayed cytotoxicity in cultures treated with a 1-10mM range, in increments of 1mM. Another set of experiments tested a 10-100mM range, in 10mM increments. Each concentration was tested in octuplicates, and three plates per set were tested (1-10mM or 10-100mM). After incubation for 24 hours, media was removed from wells and cells were washed in sterile PBS 
Cell viability assay
To test if aminoguanidine could induce cell toxicity in irradiated cells, cell suspensions from untreated and treated with 1 or 2mM of aminoguanidine in medium for 24 hours prior to irradiation were irradiated at increasing doses (0.5, 1, 2, 4, 8Gy) of gamma radiation using a 
Micronucleus frequency in binucleated cells
Genotoxicity tests using micronucleus frequency in binucleated cells (BNC) were performed using a modified protocol. Conventional microscopy glass slides were cut into 40 x 25mm pieces, washed and sterilized to further use in cell culture conditions. To prepare the experiment, glass pieces were placed inside plastic Petri dishes (6cm 
Survival fractions
For clonogenic potential assessment, cells were tripsinized and suspended in PBS for irradiations following above description. 
Calculation methods and statistical analysis
IC 50% from microplate assays and LD 50% values from survival fraction experiments were fitted to the sigmoidal dose-response equation
, where survival fraction values were represented by "Y" and dose values were inputs of "X". 
where SF values were represented by "Y" and radiation doses by "X". "A", "B" and "C" fit coefficients (independent, linear and quadratic, respectively) from untreated and treated cultures were also tested by F-test as described. Unfitted SF values were compared using twoway ANOVA and Bonferroni post-tests, and were considered different if p<0.05.
All analyses were performed using Prism7 (GraphPad Prism, San Diego, California, USA) software.
RESULTS AND DISCUSSION
Aminoguanidine IC 50% and choice of subsequent concentrations
The present work chose to use aminoguanidine as a NO production inhibition due to its selectivity to reduce only the nitric oxide synthase-2 activity [9] . After fitting of data (R 2 :
0,9503), analysis of decreases of relative cell growth could show that aminoguanidine reduced relative cell growth in 50% if used at a 22.6mM concentration (Figure 1 ). This value was used to set aminoguanidine concentrations for subsequent experiments, as 1 and 2mM did not induced statistically significant cytotoxicity in cultures (data not shown). Value of inhibitory concentration was found to be consistent to other works [12, 13] , and allowed to proceed experimentation of non-citotoxic concentrations. Aminoguanidine administration could induce significant differences in cell toxicity on irradiated cells: Treatment with 1mM of aminoguanidine reduced significantly (p<0.01) cell viability 48 hours after irradiation when cultures were irradiated with 0.5Gy, compared to non-treated control irradiated with same dose. In cultures treated with 2mM, cell viability showed reduction (p<0.01) only on those irradiated with 8Gy ( Figure 2 ). Aminoguanidine administration, and thus reduction of intracellular NO amount was found to be a radiossensitizing factor as in other works [14] [15] [16] , in a contrary notion that NO production inhibition could prevent animal models [17] or cells [18] from radiotoxicity. Its effect was related to induction of DNA double-strand breaks (DSB) in non-irradiated bystander cells [1] .
Figure 2: Effects on MCF7 cell viability upon aminoguanidine administration combined with gamma-radiation. Cultures treated with increased concentrations of aminoguanidine and/or radiation doses. (): p<0.01. Comparisons to untreated controls irradiated at same dose. Bars in columns represent SEM.
Although there are certain experimental designs that allow some equivalence between the results obtained from cytotoxicity and clonogenic potential assays [19] , it is widely accepted that clonogenic potential assays better describe the antiproliferative effects of ionizing radiation [20] . Nevertheless, there is a need to highlight any effects of the administration of the nitric oxide synthase inhibitor on the viability of the irradiated cells, as shown in Figure 2. 
Micronuclei frequencies from treated groups are different compared to controls
Modifications of the protocol of quantification of micronucleus in cytokinesis-block assays were tested prior to statistical analysis of data. 
Figure 4: Quadratic response of percentage of binucleated cells with micronuclei (% MNBNC) in untreated MCF7 cells irradiated at indicated doses. Bars in data points represent
SEM.
Significant differences between controls and groups treated with 1mM of aminoguanidine were observed. Those cultures showed an increase in total percent of BNC with micronuclei (% MNBNC) and percent of BNC with only one micronucleus (% SMNBNC) (Figures 5a and   5b ) in some doses. Alternatively, treatment with 2mM reduced significantly total percent of BNC with micronuclei and with multiple micronuclei inside cytoplasm (% MMNBNC) in cultures irradiated at 2Gy (Figures 5a and 5c) . A broader view of this experiment could suggest that 1mM treatment induced radiosensitivity, and 2mM treatment could protect cells from genotoxic damage, especially at 2Gy dose. Other works showed a biphasic response of nitric oxide synthase (and nitric oxide production) inhibition on radioinduced DNA lesions [27] by dicentric chromosome frequency assay. The micronucleus frequency test used in this work could show results in concordance. 
Figure 5: Micronuclei frequency in cultures untreated or treated with 1 or 2mM of aminoguanidine and irradiated at indicated doses. (a) Percentage BNC with micronuclei given in percent of binucleated cells (MNBNC). (b) Percentage of BNC with only one micronucleus (SMBNC). (c) Percentage of BNC with more than one micronucleus (MMBNC
Aminoguanidine induced significant differences in survival fractions
fits to exponential growth model 
Aminoguanidine reduced radiation induced LD 50%
Survival fraction data were transformed to obtain dose values in a logarithmic scale and then fitted to a sigmoidal dose-response model as for the IC 50% experiments (Figure 8 ), aiming to observe possible effects of aminoguanidine treatment on LD 50% values from irradiated cultures. Relevant coefficients for statistical analysis are in Table I . Data from all groups could be well fitted to model. F-tests found a significant difference (p=0.0097) between Log LD 50%
values from untreated and treated with 1mM (LD 50% values were 1.207 and 0.5731 Gy, respectively) but no when these groups were compared to 2mM (1.278 Gy). The LD 50% value of untreated controls was used for set maximum doses for micronucleus frequency assessment experiments as no more than 2Gy. 
CONCLUSION
Altough no dose-dependent effects could be observed regarding its relationship with radiation exposures, aminoguanidine treatment induced changes in cell viability, clonogenic potential and frequency of non-repaired DNA breaks (as micronuclei). It has been reported previously that aminoguanidine has an effect of cell cycle arrest in the G2/M phases in some cell types [29] . Irradiation can also extend duration of S and G2 phases, [30] , which turns DNA and thus cells more sensitive to clastogenic effects [31, 32] as those caused by ionizing radiations. Treatment with 1mM increased DNA damage occurrence, as assessed by micronucleus frequency, which may have led to interphasic death in cultures irradiated by 0.5Gy, and induced loss of clonogenic potential (proliferative death) in cultures irradiated by higher doses, therefore reflecting on a lower LD 50% value (0.5731 Gy, against 1.207 Gy in controls).
Treatment with 1mM also induced a prominent reduction of survival fractions in cultures irradiated by 0.5Gy. Presence of NO in human glioblastoma cells were found to confer resistance to radiation-induced clonogenic death, inhibiting amounts of apoptosis-related proteins [33] . In a macrophagic cell line, NO presence in irradiated cells were found to be a glutathione (GSH) inducer, acting as an anti-oxidant molecule; and as an enhancer of the repair protein DNA-PK (DNA-dependent protein kinase) [34] . In this perspective, the putative reduction of intracellular NO can be related to the increase of genotoxicity and thus, cell death observed in 1mM-treated cultures.
In in vivo experiments, aminoguanidine treatment showed a remarkable antioxidant activity in lung cells [35] and in intestinal crypt cells [36] irradiated with therapeutic doses. Also, aminoguanidine was found to be protective against action of intracellular reactive oxygen species (ROS) in many cell types [37] [38] [39] . As elevated ROS levels are related to radiation effects and to an increase on DNA damage [40] [41] [42] [43] , these properties can explain the reduction of genotoxicity in cells treated with 2mM, and its consequential radio-resistance. Apparently, the 1mM concentration was sufficient to reduce intracellular NO concentration enough to inhibit the anti-apoptotic and the activity of DNA repair proteins cited above, and 2mM was sufficient to reduce ROS accumulation, what could lead to cell death. Although also acting reducing the mentioned cascades, the last concentration seemed to protect MCF-7 cells from radiation damage. In cultures treated with 2mM of aminoguanidine, radiation-induced genotoxic damage showed significant reduction comparing to controls, according to a most frequent view of NO presence in irradiated cultures. In this way, NO reduction could lead to a decrease of peroxynitrite formation, and thus reducing frequencies of DNA lesions, assessed by micronucleus frequency test. In an opposite way, aminoguanidine treatment could increase genotoxic damage, and reduced survival fraction and LD 50% of breast cancer cells when administered in 1mM concentration, which could suggest collateral roles of NO production on biological radiation effects in tumor cells.
